CD47
Showing 26 - 50 of 2,804
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (procedure, biological,
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Biopsy
- +5 more
- (no location specified)
Apr 8, 2023
Multiple Myeloma Trial in United States (TTI-622, Daratumumab Hyaluronidase-fihj)
Recruiting
- Multiple Myeloma
- TTI-622
- Daratumumab Hyaluronidase-fihj
-
Basking Ridge, New Jersey
- +6 more
Dec 8, 2022
Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular
Recruiting
- Aggressive B-Cell Non-Hodgkin Lymphoma
- +19 more
- CD47 Antagonist ALX148
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 9, 2022
Advanced Solid Tumor Trial in Kogarah (HX009)
Active, not recruiting
- Advanced Solid Tumor
-
Kogarah, New South Wales, AustraliaSt George Private Hospital
Jul 7, 2021
Solid Tumor Trial in Beijing (SHR2150, Anti-Cancer Agent)
Unknown status
- Solid Tumor
- SHR2150
- Anti-Cancer Agent
-
Beijing, Beijing, ChinaBiotherapeutic Department of Chinese PLA General Hospital
Oct 15, 2020
Erythematotelangiectatic Rosacea Trial in United States (CD07805/47, CD07805/47 )
Completed
- Erythematotelangiectatic Rosacea
- CD07805/47
- CD07805/47 placebo
-
Hot Springs, Arkansas
- +4 more
Feb 16, 2021
Rosacea Trial in United States (CD07805/47 Gel, Vehicle Gel)
Completed
- Rosacea
- CD07805/47 Gel
- Vehicle Gel
-
Hot Springs, Arkansas
- +19 more
Feb 24, 2021
Rosacea Trial in Canada, United States (Brimonidine 0.33% gel (Br), CD07805/47 (Br) gel, Ivermectin 1% cream (IVM))
Completed
- Rosacea
- Brimonidine 0.33% gel (Br)
- +3 more
-
Fort Smith, Arkansas
- +12 more
Feb 16, 2021
Tumors Malignant Trial in Australia (AK117)
Not yet recruiting
- Neoplasms Malignant
-
Sydney, New South Wales, Australia
- +4 more
Apr 14, 2020
"Don't Eat me" Signal in Hematological Malignancies: CD24 as New
Recruiting
- Mantle-cell Lymphoma
- B Cell Chronic Lymphocytic Leukemia
-
Monza, MB, ItalyAndrea Aroldi
May 24, 2023
Advanced Tumors Trial (HMPL-A83 injection)
Not yet recruiting
- Advanced Tumors
- HMPL-A83 injection
- (no location specified)
Jun 17, 2022
FAPI in Rectal Cancer TNT
Not yet recruiting
- Rectal Neoplasms Malignant
- Ga-68 FAPI
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Nov 27, 2023
NSCLC, Squamous Cell Carcinoma of the Head and Neck, Ovarian Cancer Trial in United States (PF-07257876)
Recruiting
- Non-Small Cell Lung Cancer
- +2 more
- PF-07257876
-
Phoenix, Arizona
- +38 more
Jun 28, 2022
Myeloid Derived Suppressor Cells Control by Signal Regulatory
Completed
- Hepatocellular Carcinoma
- Collection of human samples
- (no location specified)
Sep 10, 2021
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in United Kingdom (Hu5F9-G4)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
-
Cardiff, United Kingdom
- +4 more
Feb 19, 2019
Advanced Cancer Trial in Guangzhou, Shanghai (TQB2928 injection)
Recruiting
- Advanced Cancer
- TQB2928 injection
-
Guangzhou, Guangdong, China
- +1 more
Feb 15, 2022
Erythrocytosis, Erythropoiesis Abnormal Trial in Copenhagen (Recombinant human erythropoietin)
Completed
- Erythrocytosis
- Erythropoiesis Abnormal
- Recombinant human erythropoietin
-
Copenhagen, DenmarkDepartment of Nutrition, Exercise and Sports
Apr 25, 2023